- NCATS Toolkit for Patient-Focused Therapy Development: Demonstration and Dissemination Meeting
- Translational Medicine 2017: Enhancing Predictivity in Medicines Development
June 30, 2017
9 a.m. to 4:15 p.m.
John Edward Porter Neuroscience Research Center
National Institutes of Health
35 Convent Drive
Bethesda, Maryland 20892
Register now for the inaugural NCATS Day — Partnering with Patients for Smarter Science. The purpose of the event is to inform patients and their advocates about NCATS and its programs, identify patient needs, and collectively discuss ways for improved patient inclusion in NCATS’ translational science activities. Admission is complimentary, but space is limited so be sure to register early.
The full day event will feature presentations, interactive activities and a poster session. Designed for patients, families, caregivers and patient advocacy groups, the event will foster an open dialogue among patients and their advocates to discuss common translational science roadblocks, brainstorm ideas for improvement, and apply that knowledge to strengthen patient and community engagement at NCATS. Join in the conversation on June 30, 2017, via #NCATSDay on Twitter.
Global Foundation for Peroxisomal Disorders (GFPD) 2017 Scientific Conference: Development of Therapies for Peroxisome Biogenesis Disorders
July 13–14, 2017
Embassy Suites by Hilton at the Chevy Chase Pavilion
4300 Military Road, N.W.
Washington, DC 20015
NCATS Director Christopher P. Austin M.D., and NCATS’ James Inglese, Ph.D., will discuss rare disease therapy development at NCATS during the 2017 GFPD conference. Inglese also will moderate the “Small Molecule Therapies Targeting Peroxisome Assembly” session on Thursday, July 13. The Development of Therapies for Peroxisome Biogenesis Disorders conference aims to create an innovative and interactive forum for a diverse group of investigators, trainees and patient advocates to discuss emerging therapeutic opportunities relevant to the treatment of peroxisome biogenesis disorders.
Aug. 7, 2017
8 a.m. to 5 p.m.
William F. Bolger Center
9600 Newbridge Drive
Potomac, Maryland 20854
NCATS is supporting this full-day workshop that will cover a broad range of critical concepts underlying assay development for high-throughput screening and lead discovery projects. This workshop, which will feature presentations by several NCATS staff members, is designed to disseminate critical information about the implementation of robust assay methods and is particularly relevant for researchers developing bioassays for the discovery of drugs or chemical probes. Many of the workshop instructors have 20 to 30 years of experience in the field of drug discovery.
Along with the Assay Guidance Manual, this workshop will be a valuable resource for academic, industrial and government laboratory scientists who are developing test methods for low- or high-throughput screening that are amenable to automation using appropriate statistical and operational concepts. It will also be beneficial to early career researchers and experienced investigators who wish to learn about the latest assay concepts for high-throughput screening and lead optimization.
Website coming soon • Agenda
SAVE THE DATE!
Sept. 8, 2017
9 a.m. to 4 p.m.
Natcher Conference Center Atrium
National Institutes of Health Main Campus
Bethesda, Maryland 20892
NCATS urges rare disease community members to save the date for this meeting to officially launch the NCATS Toolkit for Patient-Focused Therapy Development website. Patients, their caregivers and patient-support organizational representatives are invited to attend to learn how the Toolkit can streamline the search for the right tools to help in their therapeutic development activities. Participants also will have the opportunity to provide additional insights into how the Toolkit can be expanded and otherwise made even more helpful. Watch this space for more details to come, including registration and agenda information.
Sept. 24–26, 2017
Prague 4, 140 69
NCATS Director Christopher P. Austin, M.D., will deliver a keynote address on Tuesday, Sept. 26, 2017, during the “Developing More Predictive Preclinical Tools to Better Reach Proof of Concept” plenary session of Translational Medicine 2017. This third biannual conference, organized by the European Advanced Translational Research Infrastructure in Medicine (EATRIS), is open to a wide range of stakeholders, including academic researchers, funders, industry players and regulators, and will bring together international experts to discuss the latest advancements in translational medicine.
The conference will focus on the latest approaches to increase chances of success in drug development, from novel in vitro systems to new biomarkers or clinical trial methodologies for patient selection and stratification.